Table 3.
Baseline Information on Different Ablation Outcomes in Patients with the Successful Downstaging Group
| Characteristics | Level | Complete Ablation Group | Incomplete Ablation Group | P values |
|---|---|---|---|---|
| (n=25) | (n=6) | |||
| Number of tumors | 1.28 (1–2) | 1 (1–1) | 0.309 | |
| Maximum tumor diameter (mm) | 27.76 ± 10.77 | 26.8 ± 10.24 | 0.850 | |
| Total tumor diameter (mm) | 31.52 ±15.78 | 26.8 ± 10.24 | 0.497 | |
| Proximity to large blood vessels/gallbladder | Have | 6 (24.0%) | 5 (83.3%) | 0.013 |
| None | 19 (76.0%) | 1 (16.7%) | ||
| AFP (ng/mL) | <400 | 21 (84.0%) | 2 (33.3%) | 0.026 |
| ≥400 | 4 (16.0%) | 4 (66.7%) | ||
| TBL (g/L) | 15.05 ± 5.07 | 15.00 ± 5.76 | 0.984 | |
| ALB (μmol/L) | 40.34 ± 5.88 | 37.67 ± 7.46 | 0.348 | |
| ALT (U/L) | 24.68 ± 8.11 | 24.67 ± 4.55 | 0.997 | |
| Cr (μmol/L) | 54.80 ± 9.08 | 49.83 ± 8.30 | 0.232 | |
| PT (s) | 12.40 ± 1.25 | 12.27 ± 0.90 | 0.814 |